Lukes S A, Romero C A, Resnekov L
Br Heart J. 1979 Feb;41(2):187-91. doi: 10.1136/hrt.41.2.187.
Twenty-one patients in severe congestive heart failure refractory to conventional medical management were treated with sodium nitroprusside on 22 occasions. On 14 occasions (responders) there was significant improvement in clinical and haemodynamic indices. On 8 occasions (non-responders) hypotension developed without haemodynamic improvement and nitroprusside treatment had to be abandoned. The initial mean arterial pressure and the capillary wedge pressure tended to be higher in the responders while the cardiac index tended to be higher in the non-responders. The systemic vascular resistance was higher in the responders than in the non-responders (2560 +/- 160 vs 1800 +/- 180 dynes s cm-5, P less than 0.001). All of the responders had systemic vascular resistance greater than 1900 dynes s cm-5, while only one of the non-responders had a systemic vascular resistance in this range. Thus, a variable response to vasodilator therapy for congestive cardiac failure is documented. The favourable response appears to be limited to patients with a high systemic vascular resistance.
21例对传统药物治疗无效的重度充血性心力衰竭患者接受了22次硝普钠治疗。14次治疗(有反应者)时,临床和血流动力学指标有显著改善。8次治疗(无反应者)时出现低血压且血流动力学无改善,不得不停止硝普钠治疗。有反应者的初始平均动脉压和毛细血管楔压往往较高,而无反应者的心脏指数往往较高。有反应者的全身血管阻力高于无反应者(2560±160与1800±180达因·秒·厘米⁻⁵,P<0.001)。所有有反应者的全身血管阻力均大于1900达因·秒·厘米⁻⁵,而无反应者中只有1例全身血管阻力在此范围内。因此,记录到充血性心力衰竭患者对血管扩张剂治疗的反应存在差异。良好反应似乎仅限于全身血管阻力高的患者。